Victory Medical Center Pharmacy Recalls Tirzepatide/L-Carnitine Vials
Victory Medical Center Pharmacy is recalling 63 vials of Tirzepatide/L-Carnitine 10/50mg/mL due to a lack of processing controls.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The source identifies a lack of processing controls as the hazard for this Class II drug recall. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
Victory Medical Center Pharmacy in Austin, Texas, is recalling 63 vials of Tirzepatide/L-Carnitine 10/50mg/mL (MDV) 1mL. The recall is being conducted because of a lack of processing controls. The affected product includes Lot 2024992 with an expiration date of 10/20/2026, and Lot 2058102 with an expiration date of 11/1/2026.
The recalled product was distributed in Colorado, Florida, and Texas. The FDA has classified this recall as Class II, which indicates that use of or exposure to the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Consumers who have this product should stop using it and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- TIRZEPATIDE/L-CARNITINE **10/50MG/ML** (MDV) **1ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
- Manufacturer
- Victory Medical Center Pharmacy
- Category
- Drug — Injectable Medication
- Hazard
- Affected units
- 63
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (5)
- Lot
- expiry: Lot 2024992
- exp 10/20/2026
- Lot 2058102
- exp 11/1/2026
Distribution
Related recalls
Same manufacturer · Victory Medical Center Pharmacy
See all →- ModerateVictory Medical Center Pharmacy Recalls CJC-1295/IPamorelin Due to Processing Controls
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Thymosin Alpha-1 Vials
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Ascorbic Acid Vials Due to Processing Controls
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Tesamorelin Vials for Processing Control Issues
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Dexpantenol Due to Processing Controls
FDA (Drugs) · 2026-11-11
Same hazard · processing controls
See all →- ModerateVictory Medical Center Pharmacy Recalls Methylcobalamin Vials Due to Processing Controls
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Semaglutide/L-Carnitine Vials
FDA (Drugs) · 2026-11-11